You are here

  • Home
  • Archive
  • Volume 4, Issue 7
  • Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol

Citation Tools

Article menu

Download PDFPDF

XML
Research methods
Protocol
Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Anholm C, Kumarathurai P, Klit MS, et al
Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol
BMJ Open 2014;4:e005942. doi: 10.1136/bmjopen-2014-005942